RETRACTED ARTICLE: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial
We, the Editor and Publisher of Hypertension in Pregnancy, have retracted the following article: Mohamed Rezk, Mohamed Emarh, Alaa Masood, Ragab Dawood, Elsayed El-Shamy, Awni Gamal & Hassan Badr (2020) Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hyper...
Saved in:
Main Authors: | Mohamed Rezk (Author), Mohamed Emarh (Author), Alaa Masood (Author), Ragab Dawood (Author), Elsayed El-Shamy (Author), Awni Gamal (Author), Hassan Badr (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statement of Retraction: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial
Published: (2023) -
Expression of Concern: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial
Published: (2022) -
RETRACTED ARTICLE: First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk
by: Mohamed Rezk, et al.
Published: (2018) -
Degradation of Methyldopa by Banana
by: Kiminori Mohri, et al.
Published: (2010) -
Attenuation of cardiovascular responses to tracheal extubation with labetalol
by: Mokhtar M Younes, et al.
Published: (2017)